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Abstract
Aim: To assess the technical feasibility and clinical outcome of percutaneous transluminal angioplasty (PTA) with
and without stent placement for treatment of buttock claudication caused by internal iliac artery (IIA) stenosis.
Methods: Between September 2001 and July 2011, thirty-four patients with buttock claudication underwent
endovascular treatment. After angiographic lesion evaluation PTA with or without stent placement was performed.
Technical success was recorded. Clinical outcome post-treatment was assessed at three months post-intervention
and was classified as: 1) complete relief of symptoms, 2) partial relief, or 3) no relief of symptoms. Complications
during follow-up were recorded.
Results: Forty-four lesions in 34 symptomatic patients were treated with PTA. Eight lesions were treated with
additional stent placement. Technical success was achieved in 40/44 lesions (91%). Three procedure-related minor
complications occurred, i.e. asymptomatic conservatively treated intimal dissections. After a median of 2.9 months,
patients experienced no relief of symptoms in 7/34 cases (21%), partial relief in 14/34 cases (41%), and complete
relief in 13/34 cases (38%). Six patients required a reintervention during follow-up.
Conclusion: Endovascular treatment of IIA stenosis has a high technical success rate and a low complication rate.
Complete or partial relief of symptoms is achieved in the majority (79%) of patients.
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Introduction
Internal iliac artery (IIA) stenosis may lead to symptoms
including pain in the buttocks or hips, extending to the upper
leg [1]. In males, impotence can be found. The pain can be
difficult to differentiate from coxarthrosis or neurogenic
claudication [2,3].
Upon clinical suspicion of IIA stenosis, an ankle brachial
pressure index can be normal as this does not include, or may
not optimally visualize, the whole IIA. Color flow duplex
ultrasonography (DUS) and computed tomography
angiography (CTA) and/or magnetic resonance angiography
(MRA) can confirm the presence of an isolated IIA stenosis or a
combined IIA stenosis with stenotic inflow of the common iliac
artery [4].
Treatment options range from a) conservative management
including exercise therapy, life-style changes, and antiplatelet
therapy, to b) minimally invasive endovascular treatment, i.e.
percutaneous transluminal angioplasty (PTA), with or without
stent placement, supported by antiplatelet therapy [4–6].
There is scant literature on the technical efficacy and clinical
outcome of endovascular treatment of IIA in patients with
buttock claudication [7]. Furthermore, little data has been
reported on the durability of symptom relief following
endovascular treatment.
In this study the technical feasibility, safety, and three
months clinical outcome with mid-term patency rates of
endovascular treatment, including PTA with or without stent
placement, were assessed in patients with buttock claudication
due to angiographically confirmed significant internal iliac artery
stenosis.
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Materials and Methods
Definition of buttock claudication
Symptomatic buttock claudication was defined as a
composite of two findings. First, the presence of invalidating
and intermittent pain and/or weakness in the buttock or thigh
related to walking/exercise, as reported by the patient. Second,
the finding of a significant stenosis in the IIA on the
symptomatic side, defined as a reduction of more than 50% of
the vessel diameter, as found on digital subtraction
angiography (DSA).
Patient selection
Between September 2001 and July 2011, all consecutive
patients undergoing endovascular treatment for buttock
claudication due to IIA stenosis with or without concomitant
inflow stenosis in the common iliac artery (CIA) were included.
Patients without concomitant lesions were analyzed separately
to prevent confounding. Patients with IIA occlusion were not
considered appropriate candidates for revascularization and
were excluded from the present analysis. All baseline
characteristics, data of the endovascular procedure (including
treatment of concomitant lesions) and follow-up were
retrospectively collected from the medical records.
Ethics statement
The institutional review board of the University Medical
Center Utrecht (Utrecht, the Netherlands) approved this
retrospective case cohort study and issued a waiver for patient
informed consent.
Clinical workup
Patients with complaints of buttock claudication were seen
by a vascular surgeon. Neurologic and orthopedic causes were
excluded based on anamnesis and physical examination if
possible, or referred to the relevant specialist. Upon suspicion
of a lesion in the iliac arteries, DUS, CTA, or MRI was
performed. If an arterial iliac lesion was shown, the treatment
indication was confirmed in a multidisciplinary vascular meeting
with vascular surgeons and interventional radiologists present.
A DSA was then performed, of which details can be found
below.
Treatment
All patients were referred to the cathlab for endovascular
treatment. Patients were treated by an experienced
interventional radiologist.
Following subcutaneous injection of 1% xylocaine, a sheath
was introduced in the ipsi- or contralateral femoral artery. The
brachial artery was used if access using the iliac vessels was
not feasible, e.g. due to a steep angle of both CIAs with the
abdominal aorta. In total, 2500 units of heparin were
administered. When the femoral artery was punctured, a 6
French (F) sheath was placed over the aortic bifurcation. The
stenosis was confirmed on DSA using Visipaque 270 contrast
(GE Healthcare, Little Chalfont, UK). If necessary, additional
oblique projections were made and vessel sizes were
measured. The grade of stenosis was assessed.
If the IIA stenosis was accompanied by a significant stenosis
(>50%) in the external iliac artery (EIA) or CIA, additional
lesions were treated by either PTA or stent placement. An
angled guide wire was used to pass the stenosis, followed by
placement of a balloon catheter. The balloon was inflated to
nominal pressure using a calibrated inflation device for two
minutes (Basix Compak, Merit Medical, Galway, Ireland). After
treatment, the response was evaluated on DSA. If PTA was
unsuccessful (i.e. the angiographically assessed stenosis
grade remained ≥30%), additional placement of a balloon-
expendable metal stent (Palmaz Blue, Cordis) was considered.
Clinical follow-up consisted of a visit to the outpatient
department 3 months after treatment. Patients were discharged
from outpatient control if they were symptom-free or with
sufficient symptom relieve, and were requested to return if
symptoms re-occurred.
End point definition
The primary endpoint of our study was severity of buttock
claudication three months post procedure as compared to the
prior situation. This comparison was quantified in three
categories: 1) complete relief of symptoms, 2) partial relief, or
3) no relief of symptoms. Patients’ complaints were subjectively
assessed by a vascular surgeon with regard to buttock pain
free walking distance, intensity of pain during exercise, and rest
pain. Secondary endpoints were technical success, defined as
angiographic residual lumen stenosis <30%, periprocedural
complications, the need to perform reintervention, and
occurrence of occlusion during follow up. To exclude
confounding by concomitant lesions, the subgroup of patients
with treatment of only IIA stenosis was also assessed
separately.
Statistical analysis
Patency of treated vessels was expressed as primary and
secondary patency rate.
Primary patency was defined as uninterrupted patency with
no additional procedure performed. Secondary patency was
defined as if patency was restored by an additional intervention
(in accordance with published guidelines) [8].
The timing of angiographic confirmation of patency loss was
used for patency rate calculations with Kaplan-Meier method. A
cut-off of 10% of standard error of patency rate estimate was
applied.
All risk factors and treatment characteristics were
univariately analyzed for prediction of a favorable treatment
response. Clinical outcome was dichotomized in patients with
none to partial relief of complaints, and patients with complete
relief of symptoms. Variable were analyzed using a two-tailed
Fisher’s exact test and p-values were calculated. A p-value
smaller than 0.05 was considered statistically significant.
Analyses were performed using SPSS, version 15 (IBM, North
America, New York, NY, USA).
Treatment of Internal Iliac Artery Stenosis
PLOS ONE | www.plosone.org 2 August 2013 | Volume 8 | Issue 8 | e73331
Results
Patients
A total of 44 stenotic IIA lesions in 34 patients were treated.
Of these patients, 31 were male. The median age was 67 years
(range 52-83 years). Some patients experienced bilateral
buttock claudication (16/34, 47%), others only on the right
(9/34, 26%) of left side (9/34, 26%). Most patients had earlier
treatment for PAD (n=29), hypercholesterolemia (n=29), or
hypertension (n=27). Further baseline characteristics and the
presence of other risk factors are presented in Table 1.
Lesions
After pre-procedural workup using DUS, CTA, or MRA, a
DSA showed 35/44 lesions (80%) in the IIA origin, and 9/44
(20%) more distal IIA lesions. A concomitant lesion of the
contralateral IIA (stenosis or occlusion) was present in 15/34
(44%) patients, of which 7 experienced bilateral complaints. An
ipsilateral CIA stenosis was present in 6/34 (18%) of the
patients.
Treatment
Percutaneous transluminal angioplasty of the IIA stenosis
was performed in all patients. The mean balloon diameter used
Table 1. Baseline characteristics.
Characteristic  
Number (percentage)
or median (range)
Gender Male 31 (91%)
 Female 3 (9%)
Age (years)  67 (52-83)
Fontaine
classificationa 1 0 (0%)
 2a 12 (35%)
 2b 19 (56%)
 3 2 (6%)
 4 1 (3%)
Side of buttock
complaints Left 9 (26%)
 Right 9 (26%)
 Both 16 (47%)
ABI of treated limb  0.96 (0.39-1.51)
Risk Factorsb Smoking 12
 Overweight (BMI >25) 20
 Diabetes 14
 Hypertension 27
 Hypercholesterolemia 29
 Familial risk factors 15
 Earlier invasive treatment forPAD 29
 Impotence 3
a of lower extremity
b if reported in medical records, as such, no percentage calculation was possible
ABI = ankle brachial pressure indexPAD = Peripheral artery disease
Percentages might not add up to 100% due to rounding
was 5mm (range 3-7mm). In eight patients, the stenosis was
not sufficiently relieved, or relapsed, and a balloon-expandable
bare-metal stent (5-8mm in diameter) was placed in the IIA in
addition to the PTA. The ipsilateral CIA was treated in 5/44
(11%) of the lesions. A bilateral treatment of both IIAs was
performed in 10/34 (29%) patients. Treatment characteristics
are summarized in Table 2 and the inclusion, treatment, and
results are displayed in Figure 1. Technical success was
achieved in 40 out of 44 (91%) lesions (Figure 2). In four
patients >30% stenosis remained after endovascular treatment.
Complications
Procedural related complications occurred in 3/34 patients
(9%). In one patient, a small dissection developed in the
ipsilateral CIA during treatment. The second patient underwent
treatment for both the IIA and the EIA. In the EIA, a small
dissection was caused at the bifurcation. Blood flow was not
compromised in both cases and both dissections were
conservatively treated. The third complication occurred upon
passing the stenosis in the left IIA. A dissection was caused,
which obstructed the vessel lumen. The contralateral IIA
stenosis was successfully treated. During follow-up, the patient
reported neither deterioration nor improvement of complaints.
Table 2. Diagnosis, treatment and clinical outcome.
Characteristic  Number (%)
Diagnosis Lesions / Patients 44/34
 Contralateral IIA occlusions 4/34 (12%)
 Contralateral IIA or CIA stenosis 15/34 (44%)
 Ipsilateral CIA stenosis 6/34 (18%)
 Bilateral IIA stenosis or occlusion 15/34 (44%)
 Origin stenosis 35/44 (80%)
 Stent CIA or EIA causing stenosis 5/44 (11%)
Treatment Access via femoral artery 30/34 (88%)
 Access via brachial artery 4/34 (12%)
 Size balloon PTA (3mm-4-5-6-7) 7-11-8-16-2
 Stents placed 8/34 (24%)
 Isolated IIA treatment 22/34 (65%)
 Bilateral IIA treatment 10/34 (29%)
 CIA treatment ipsilateral 5/44 (11%)
 Technical success 40/44 (91%)
 Complications 3/34 (9%)
Clinical Outcome After 3
Months (total of 34 patients) Group 1 (no relief) 7 (21%)
 Group 2 (partial relief) 14 (41%)
 Group 3 (total relief) 13 (38%)
Clinical Outcome After 3
Months for patients with isolated
IIA treatment (total of 22
patients)
Group 1 (no relief) 5 (23%)
 Group 2 (partial relief) 8 (36%)
 Group 3 (total relief) 9 (41%)
CIA = Common iliac arteryEIA = External iliac arteryIIA = Internal iliac arteryPTA =
Percutaneous transluminal angioplasty
Treatment of Internal Iliac Artery Stenosis
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Figure 1.  Flowchart of study design.  IIA = Internal Iliac Artery. CIA = Common Iliac Artery. EIA = External Iliac Artery.
doi: 10.1371/journal.pone.0073331.g001
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Primary endpoint: follow up at three months
After a median of three months, 7/34 (21%) patients reported
no symptomatic relief. One patient was diagnosed with
coxarthrosis shortly after IIA treatment. On the other hand,
14/34 (41%) patients experienced a significant improvement
while 13/34 (38%) patients had a complete relief of symptoms.
Of all patients treated, 22 patients received treatment for
solely their IIA lesion, and no other inflow arteries. In this
subgroup, 30 lesions were treated. After a median of 2.9
months, 5/22 (23%) patients did not experience symptomatic
relief. A total of 8/22 (36%) patients experienced partial
improvement, and in 9/22 (41%) patients the buttock
claudication disappeared completely.
Follow up
After a median follow up of 10 months (range 1-116 months)
in the full cohort of 34 patients, three patients presented with
ipsilateral occlusion of the iliac tract (3/34, 9%). One patient
developed an occlusion in the CIA extending into the IIA, 12
months after initial treatment. This patient successfully received
thrombolytic treatment and additional stent placement in the
EIA for signs of a dissection. Another patient developed an EIA
occlusion distal of a prior placed CIA stent, 8 months after
treatment. The IIA was patent. This patient received urokinase
treatment with good effect, and antithrombotic therapy
consisting of acenocoumarol was added to her antiplatelet
therapy. A third patient had an occlusion of the treated IIA,
discovered 68 months after PTA treatment. Since there were
no complaints precipitating the occlusions, no time of occlusion
could be determined and it was decided not to treat.
Another 6/34 (18%) patients required reinterventions due to
progressive symptomatic restenosis at the site of the initial
target lesion, which, in all cases, occurred more than 4 months
after primary treatment. Two patients underwent re-PTA and in
four patients five additional stents were placed (Table 3).
No treatment related deaths were noted during follow-up.
Three patients died during follow-up. The death of one patient
was related to a Merkel cell carcinoma, and occurred 53
months after endovascular treatment. The other patient died
due to complications of abdominal surgery, 23 months after
treatment. The third patient died 15 months after treatment due
to an intracerebral hemorrhage.
Patency rates
The primary patency rate after 7.8 months was 77%
(standard error 9.0%). The median survival time was 30 ± 12.3
months. Since there was only one occlusion in the IIA, which
was untreated for reasons mentioned above, the secondary
patency rate had one endpoint, and the standard error
exceeded 10% for all values.
The analysis of risk factors and variables of diagnosis and
treatment did not show any particular feature which was
significantly associated with a favourable outcome.
Table 3. Follow up.
Characteristic Number (%) or median (range)
Follow up (months) 10 (1-116)
Iliac occlusions 3 (9%)
Reinterventions 6 (18%)
Additional stent placement (patients) 5 (15%)
Deathsa 3 (9%)
Loss to follow-upb 0 (0%)
a None were related to IIA treatment
b If no information of first visit after procedure could be obtained
Figure 2.  Treatment of a patient.  (a) Digital subtraction angiography of the left common iliac artery showing a proximal stenosis
of the internal iliac artery (IIA), with sub-optimal filling of subsequent branches. (b) Result after treatment with 5 and 6 mm
percutaneous transluminal angioplasty, showing residual origin stenosis of the IIA of more than 30%. (c) Subsequent stent
placement (Palmaz 6 mm diameter) reduced the stenosis grade to less than 30%, and provided adequate distal blood flow. (d)
Overlay of Figure c showing branches of mentioned vessels, guide wire position (white dotted line) and placed stent (white mesh).
CIA = Common Iliac Artery. EIA = External Iliac Artery. IIA = Internal Iliac Artery.
doi: 10.1371/journal.pone.0073331.g002
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Discussion
Only a few studies with limited number of patients assessed
the clinical outcome of endovascular treatment of patients with
buttock claudication due to internal iliac artery stenosis (see
Table 4) [7]. In our single center experience, endovascular
treatment of IIA stenosis showed a high technical success rate.
PTA of the IIA, with or without stent implantation, seems
therefore feasible and safe, with no major complications and
acceptable rate of minor complications. After three months, the
majority of patients had (partial or complete) relief of clinical
symptoms. During further follow up the mid-term patency rate
is high.
Buttock claudication as a diagnosis may have a vascular
origin, but symptoms may also be mimicked by other disease
entities such as coxarthrosis and neurogenic claudication,
which therefore should be in the differential diagnosis at
baseline [3]. Prior studies used different methods of excluding
neurogenic or orthopedic causes, as seen in Table 4. However,
in a patient with symptoms which are relieved after a resting
period and who has a proven significant IIA stenosis our results
indicate that this patient can be offered endovascular treatment
with a low threshold.
In reviewing the outcomes after IIA PTA/selective stenting
we also performed an analysis including only patients who
were treated for isolated IIA lesions (and absence of
concomitant common iliac lesions). Severe stenotic IIA lesions
are often accompanied by concomitant stenoses in the CIA or
EIA. Treating the proximal artery (CIA) can have beneficial
effects on patient outcome by itself. When a stenosis in the IIA
extends in the EIA, and both significantly comprise the flow, a
combined treatment will be necessary (see Figure 3).
Simultaneous treatments will affect treatment outcome. The
outcome of treating solely the IIA lesion will provide more
insight. However, within the present series, the outcome of this
subgroup did not differ from the outcome of the full cohort.
During treatment of 44 lesions in 34 patients, three
complications occurred (i.e. two dissections, one occlusion).
Upon further follow up, no clinically relevant sequelae were
found in any patient. This complication rate is comparable with
other retrospective cohort studies in the literature [6,7,9].
PTA therapy (with or without stent) for IIA claudication
yielded a partial to full relief of complaints in 92% of patients.
The outcome of our treatment was evaluated after three
months by a subjective outcome measure, the complaints
reported by the patient as interpreted by the vascular surgeon.
This is a limitation, as imaging or transcutaneous oxygen
tension (TcPO2) can provide more objective measures.
Furthermore, it is difficult to quantify patients’ complaints, so a
distinction was made between full, partial or no relief.
Quantification could have been done more thoroughly using
standardized questionnaires. However, relevant literature often
describes outcome as successful or not. This study provides a
Table 4. Review of literature concerning endovascular therapy for IIA stenosis or occlusion.
Study
Type of IIA
lesions treated
Exclusion of
neurologic of
orthopedic causes n (lesions /patients) PTA
Stents
placeda
Technical
success Complications
Complete
reliefb Partial relief No relief
Morse et al. (1986)
[11] stenosis
c not mentioned 2 / 2 2 0 100% 0% 1 (50%) 1 (50%) 0 (0%)
Smith et al. (1992)[3] stenosisc not mentioned 2 / 2 2 0 100% 0% 1 (50%) 1 (50%) 0 (0%)
Batt et al. (2006)[6]
stenosis or
occlusion of
SGAc
physical
examination 7 / 6 7 0 100% 0% 5 (83%) 1 (17%)
d
Huetink et al. (2008)
[1] stenosis
c excluded, not
mentioned how 4 / 3 4 0 100% 0% 2 (67%) 1 (33%) 0 (0%)
Adlakha et al. (2009)
[12] occlusion not mentioned 2 / 2 2 2 100% 0% 2 (100%) 0 (0%) 0 (0%)
Donas et al. (2009)
[7]
stenosis or
occlusionc
clinical evaluation
+ CT-scan 22 / 21 14 8 100% 0% 21 (100%) 0 (0%) 0 (0%)
Thompson et al.
(2009)[9]
stenosis or
occlusionc not mentioned 15 / 9 7 8 100% 0% 7 (78%) 0 (0%) 2 (22%)
Prince et al. (2013)e >50% lumenobstruction
physical
examination 44 / 34 36 8 91% 9% 13 (38%) 14 (41%) 7 (21%)
IIA = Internal iliac arteryPTA = Percutaneous transluminal angioplastySGA = superior gluteal artery
a Number of stents placed in the IIA or distal arteries, treatment was sometimes accompanied by PTA
b Treatment results were classified as complete, partial or no relief based on description in article
c Minimum stenosis grade not mentioned
d Partial or no relief
e This study
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more quantified and clinically applicable outcome measure, as
seen in Table 4.
If vessel patency decreases over time, PTA can be repeated.
During follow up we performed reinterventions in four patients,
all four because of residual complaints. Patency rates might be
improved by placement of a stent [10]. Our limited number of
primary stenting (n=5), stenting only when PTA was
unsuccessful, and our retrospective study design did not allow
us to analyze possible differences between patients receiving a
stent and those who did not. Future prospective studies might
consider IIA stenting as the primary treatment approach, or
include a double treatment arm comparing primary PTA with
primary stenting.
Another limitation of this study is the lack of structural follow-
up, due to the retrospective study design. It also means that,
due to lack of data, some determinants, such as impotency,
cannot be evaluated for their association with the patients’
outcome. Impotency is a complaint often accompanying
buttock claudication [6]. This compromises the validity of
clinical outcome, and makes that our conclusions can be stated
for the three months period of follow-up only.
Conclusion
Endovascular treatment of patients with buttock claudication
due to internal iliac artery stenosis is safe and effective in
symptom relief in the majority of patients at short-term follow-
up. Longer term durability needs to be awaited.
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